A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, Among Participants Taking Multidrug Treatment for Drug-Resistant Pulmonary Tuberculosis
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2017
At a glance
- Drugs Bedaquiline (Primary) ; Delamanid (Primary) ; Dolutegravir
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 01 Aug 2017 Planned End Date changed from 1 Jan 2021 to 1 Jul 2020.
- 01 Aug 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Jul 2018.
- 25 Apr 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jan 2019.